TALPHERA, INC. Operating Lease Right-of-Use Assets
TALPHERA, INC. (TLPH) had Operating Lease Right-of-Use Assets of $0 as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-08-10
- 2023-06-30: Operating Lease, Right-of-Use Asset $0.00.
- 2023-03-31: Operating Lease, Right-of-Use Asset $49.00K.
- 2022-12-31: Operating Lease, Right-of-Use Asset $96.00K; Operating Lease, Right-of-Use Asset as first filed $3.60M.
- 2022-09-30: Operating Lease, Right-of-Use Asset $3.81M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $49.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $96.00K 10-Q · filed 2023-08-10 | $3.60M 10-K · filed 2023-03-31 |
| 2022-09-30 | $3.81M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.98M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.15M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $271.00K 8-K · filed 2023-08-01 | $4.30M 10-K · filed 2022-03-10 |
| 2021-09-30 | $4.45M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $4.61M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $312.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $3.15M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $3.29M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $3.51M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.72M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $3.93M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $4.13M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $4.33M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $4.52M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |